Endothelial miR-30c suppresses tumor growth via inhibition of TGF-β–induced Serpine1

Journal: Journal of Clinical Investigation

Published: 2019-04-01

DOI: 10.1172/jci123106

Affiliations: 17

Authors: 15

Go to article
Institutions Share
UNC Lineberger Comprehensive Cancer Center, United States of America (USA) 0.12
MIT David H. Koch Institute for Integrative Cancer Research, United States of America (USA) 0.12
Department of Microbiology, Immunology, and Cancer Biology (MIC), UVA, United States of America (USA) 0.10
UNC McAllister Heart Institute (MHI), United States of America (USA) 0.10
UNC Department of Genetics, United States of America (USA) 0.09
UNC Department of Cell Biology and Physiology, United States of America (USA) 0.07
Children's Cancer Institute Australia (CCIA), Australia 0.07
UNC Division of Hematology/Oncology, United States of America (USA) 0.07
UNC School of Medicine, United States of America (USA) 0.06
MIT Department of Chemical Engineering (ChemE), United States of America (USA) 0.05
UNC Department of Pathology and Laboratory Medicine, United States of America (USA) 0.03
Department of Public Health Sciences, UVA, United States of America (USA) 0.03
School of Medicine, UVA, United States of America (USA) 0.03
University of Virginia Cancer Center, United States of America (USA) 0.03
Harvard-MIT Health Sciences and Technology (HST), United States of America (USA) 0.02
MIT Institute for Medical Engineering and Science (IMES), United States of America (USA) 0.02

Return